Global intraosseous devices market by 2029

company logo

company logo

DUBLIN, April 15, 2022 (GLOBE NEWSWIRE) — The “Intraosseous Devices Market Size, Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 To 2029” Report has been added ResearchAndMarkets.com Offer.

This report titled provides strategic insights into the overall Intraosseous Devices market along with the market size and estimates for the period 2019 to 2029. Said research study includes in-depth analysis of several market segments on the basis of product types, technologies and different geographies.

Intraosseous infusion, a technique for vascular access, was originally described in 1922 and was widely used for drug delivery in children and adults in the 1940s. It fell out of favor in the 1950s and 1960s when disposable intravenous catheters were developed and insertion techniques improved. Intraosseous (IO) infusion is possible due to the presence of veins draining the medullary cavities in the bone marrow of the long bones.

IO is the procedure where fluids or drugs are injected into the bone marrow to provide a continuous point of entry into the systemic circulation. This technique is used to deliver fluids and medication when IV access is unavailable or not possible. There are several different commercially available intraosseous cannulation devices such as manual IO needles, semi-automatic devices, battery-powered needles, and impact-powered devices.

The primary anatomical sites for intraosseous infusion include the proximal tibia, distal femur, distal tibia or fibula, proximal humerus, and manubrium. After the fall in demand after World War II, the market for IO devices has gradually recovered as the devices gain a foothold in mainstream medicine and emergency algorithms. The majority of IO devices are indicated for use in adult and pediatric patients and are indicated when vascular access is difficult to achieve, particularly in emergency or medically necessary cases. The main driver for the intraosseous device market is the development of fast and user-friendly intraosseous placement.

North America has been observed as the leading geographic region in the intraosseous devices market due to the increasing application of IO devices in ambulatory and emergency settings, the increasing prevalence of various chronic diseases and the rising number of traumatic surgeries and military consumption, especially in cases of war. Market experts suggest that IO infusion is a fast, safe and effective technology of vascular access through the bone marrow when the intravenous attempt at vascular access fails. Asia Pacific has been observed as the market with the greatest potential for intraosseous devices with increasing acceptance of IO devices. However, the high price and lack of continuous training of medical and nursing staff as well as well-defined protocols to properly handle the device limit the market in this region.

The intraosseous devices market is considered to be the most diversified and competitive market with a large number of players. The market is dominated by several players depending on their main competencies. The major players in this market are Pyng Medical Corporation, PerSys Medical, Aero Healthcare, Vidacare/Teleflex, Becton Dickinson Company/Carefusion Inc. and Cook Medical Inc.

Based on product type, the global intraosseous devices market is segmented as follows:

Intraosseous infusion (IO) is the process of drug delivery performed directly into the bone marrow to provide an entry point into the systemic venous system. Fluids and medications are delivered through this technique when intravenous access is not available or not possible. Market experts suggest that a comparative study between intramuscular (IM), intravenous (IV) and IO routes of administration revealed that IO route of administration is obviously better than IM and comparable to IV administration, especially in case of pediatric treatment.

During the initial resuscitation administration of drugs and fluids in adults, demand for IO infusions is increasing. IO infusion should be performed in all critical situations where peripheral venous access is not readily available. These devices also have some complications that are uncommon and mostly related to prolonged use. IO infusion allows for blood collection and administration of virtually all types of fluids and drugs, including vasopressors, with bioavailability approaching that of the intravenous route. The EZ-IO devices held the largest market in the intraosseous device market by product type. The advent of automated intraosseous devices has led to the facilitation of drug and drug delivery through the intraosseous route, thereby propelling the intraosseous devices market in 2021-2029.

Based on the type of technology, the intraosseous devices market is segmented into the following:

  • Manual IO needles

  • Battery powered driver

  • Impact Operated Devices

Intraosseous (IO) access is considered an efficient first alternative to an unsuccessful or delayed peripheral or central intravenous (IV) access in emergency situations. The IO technique involves the placement of a vascular device with the tip of the intraosseous catheter in the bone matrix. The fluids or medicines are immediately delivered through the bone marrow cavity into the systemic circulation with the help of this catheter.

According to experts, the rationale for preferring an intraosseous (IO) delivery device is limited to observational studies and a few studies that vary by site (e.g., prehospital, hospital), clinical provider (e.g., paramedic, paramedic, physician), injection site and age of patient (child or adult). Proper training prior to use is essential to maximize the chance of successful IO cannulation, regardless of the IO insertion technique chosen. Manual IO needles include Jamshidi (Cardinal Health) and the modified Dieckmann (Cook Critical Care).

These are commonly used in IO access procedures because they have a special feature known as a trocar, a short length needle with a handle that provides a resting place for the palm of your hand, and an adjustable flange or depth mark to guide placement. In 2020, the battery powered driver has been observed as the largest market segment in the IO devices market. EZIO comes with a lithium-powered battery driver and needle sets in three lengths for pediatric and adult placement.

For the purposes of this study, the global intraosseous devices market is segmented into the following categories:

In the base year 2020, North America was observed as the leading geographic region in the intraosseous devices market due to the increasing application of IO devices in ambulatory and emergency settings, the increasing prevalence of various chronic diseases and the increasing number of traumatic surgeries and military consumption in cases of war. Market experts suggest that IO infusion is a fast, safe and effective technology of vascular access through the bone marrow when the intravenous attempt at vascular access fails. The EZ-IO is used by 90% of US extended life support ambulances and over half of the US emergency departments and military.

However, a report released by Vidacare Corporation suggests that during the Gulf War, the US military had 13,000 medics and 26,000 combat lifeguards using six and three intraosseous units (EZ-IO) respectively, for a total of 160,000 intraosseous devices expected to be used. Asia Pacific has been observed as the market with the greatest potential for intraosseous devices with increasing acceptance of IO devices. Recently, Pyng Medical Corp. announced the expansion of its exclusive dealer network worldwide with a significant addition to add India to the Asia Pacific markets.

Market experts assume that there is great demand in India for high-quality medical products from North America. Pyng’s dominance in Sternal IO for deployed US military is being leveraged in the Indian military, ambulance and hospital markets. However, the high price and lack of continuous training of medical and nursing staff as well as well-defined protocols to properly handle the device limit the market in this region.

Main topics covered:

Chapter 1 Preface

Chapter 2 summary

Chapter 3 Intraosseous Devices Market Analysis
3.1 Global Intraosseous Devices Market Analysis
3.1.1 Technology of intraosseous devices
3.1.2 Applications of intraosseous devices
3.1.3 Pipeline Analysis: Intraosseous Devices
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.1.1 Development of fast and easy-to-use IO assembly devices
3.2.2 Challenges
3.2.2.1 Usability Challenge/Complications in IO Access
3.2.2.2 Lack of standardized and continuous training
3.2.3 Opportunities
3.2.3.1 Potential in mass accident situations
3.3 Attractive range of investments
3.4 Key Vendor Competitive Landscape in Intraosseous Devices Market.

Chapter 4 Global Intraosseous Devices Market Analysis by Product Type
4.1 Introduction
4.2 Dieckmann modified needle
4.3 Jamshidi needle
4.4 FAST1 Device
4.5 FASTx Device
4.6 Bone Injection Gun (BIG) devices
4.7 EZ-IO Devices
4.8 NOK device

Chapter 5 Global Intraosseous Devices Market by Technology
5.1 Foreword
5.2 Manual IO needles
5.3 Battery Powered Driver
5.4 Burst Powered Devices

Chapter 6 Global Intraosseous Devices Market by Geography
6.1 Foreword
6.2 North America
6.3 Europe
6.4 Asia Pacific
6.5 Latin America
6.6 Middle East and Africa

Chapter 7 Company Profiles
7.1 Pyng Medical Corporation.
7.1.1 Pyng Medical Corporation.: Business Summary (Business Description; Financial Information; Product Position/Portfolio; Reporting)
7.2 PerSys Medical
7.2.1 PerSys Medical: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; Reporting)
7.3 Aero Healthcare.
7.3.1 Aero Healthcare.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; Reporting)
7.4 Vidacare/Teleflex.
7.4.1 Vidacare/ Teleflex: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; Reporting)
7.5 Becton Dickinson Company / Carefusion Inc.
7.5.1 Becton Dickinson Company / Carefusion Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; Reporting)
7.6 Cook Medical Inc.
7.6.1 Cook Medical Inc: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; Reporting)

For more information about this report, see https://www.researchandmarkets.com/r/93g7sy

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Leave a Reply

Your email address will not be published.